The first Pacific study on vaccine access for children with disability

May 21, 2025

Research conducted by the IDIE played a key role in a groundbreaking study in Fiji, which uncovered lower vaccination rates among children with disabilities. These findings are now guiding national policy reforms aimed at enhancing inclusion and improving access to immunisation services.

A collaborative study involving the University of Sydney, Central Queensland Hospital and Health Service, Fiji National University and several Fijian and Australian partners investigated vaccination rates among children with disabilities in Fiji. Surveying 190 children, researchers found that only 55% were fully vaccinated for their age—well below national averages. Vaccination rates were particularly low among older children, those with hearing impairments, and those whose caregivers lacked confidence in vaccine safety. In contrast, children with mobility challenges had higher coverage.

To understand the causes, the team conducted interviews and surveys with families and stakeholders. They identified several barriers, including stigma, inaccessible information and facilities, limited coordination between health and disability services, and provider hesitancy due to inadequate training.

The findings are now shaping updates to Fiji’s national immunisation policy, with a focus on improving access and inclusion for children with disabilities. The project was supported by the Australian Government through the ARIA initiative.

Find out more about the findings and our collaborators here.

You might find these interesting also…

 

Enhanced Acute Febrile Illness surveillance in Fiji

Enhanced Acute Febrile Illness surveillance in Fiji

Acute Febrile Illness (AFI) is a major cause of morbidity in Fiji, but rural surveillance system remain limited. Strengthening AFI monitoring is crucial to detecting endemic, high burden diseases like dengue, leptopsprirosis, and typhoid in Fiji. Over 18 months, the...

Meru Sheel profiled by the Lancet Infectious Diseases

Meru Sheel profiled by the Lancet Infectious Diseases

IDIE's team leader, A/Prof Meru Sheel, was recently profiled by the Lancet Infectious Diseases. The profile takes readers to her journey from vaccine development to emergency responses to training the next generation of global health practitioners and advocating for...